Skip to content
Screener

Medifast MED Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$105.6MBeat by $11.8M
EPS$0.04Beat by $0.34
Revenue estimate$93.8M
EPS estimate-$0.30

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Financials

Q2 2025

Income statement

See full
Revenue$105.6M-37.4%
Gross profit$76.6M-37.9%
Operating income-$1.1M+86.5%
Net income$2.5M+130%
EPS (diluted)$0.22+129%

Balance sheet

See full
Cash & equivalents$101.7M-5.9%
Total debt$13.1M-31.6%
Total equity$216.0M+5.2%
Total assets$269.3M-8.2%

Cash flow

See full
CapEx$1.4M-28.9%
Free cash flow-$4.8M-143%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$150.58M-36.9%
Enterprise value$61.95M-58.6%
P/E41.4×+33.3×
P/S0.3×0.0×

Profitability

See full
Gross margin73.8%-0.1pp
Operating margin0.1%-4.3pp
Net margin0.8%-3.1pp

Returns & leverage

See full
Return on equity1.7%-13.3pp
Debt / equity0.1×0.0×
Current ratio4.5×+1.5×

Segments

By segment

See full
Optavia Segment$105.6M-37.4%

FAQ

When did Medifast report Q2 2025 earnings?
Medifast (MED) reported Q2 2025 earnings on August 4, 2025 after market close.
What were Medifast's Q2 2025 revenue and EPS?
Medifast reported revenue of $105.6M and eps of $0.04 for Q2 2025.
Did Medifast beat estimates in Q2 2025?
Revenue beat the consensus estimate of $93.8M by $11.8M. EPS beat the consensus estimate of $-0.30 by $0.34.
How did Medifast's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 37.4% from $168.6M a year earlier and eps declined 95.7% from $0.92.
Where can I find Medifast's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000910329-25-000015) and the 10-Q periodic report (0000910329-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.